1-3 of 3
Hans van der Lelie
Close
Sort by
Journal Articles

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Clinical Trials & Observations
Jan J. Cornelissen, Wim L. J. van Putten, Leo F. Verdonck, Matthias Theobald, Emanuel Jacky, Simon M. G. Daenen, Marinus van Marwijk Kooy, Pierre Wijermans, Harry Schouten, Peter C. Huijgens, Hans van der Lelie, Martin Fey, Augustin Ferrant, Johan Maertens, Alois Gratwohl, Bob Lowenberg
Journal: Blood
Blood (2007) 109 (9): 3658–3666.
https://doi.org/10.1182/blood-2006-06-025627
Published: 2007
Includes: Supplemental data
Journal Articles

Randomized comparison of low-dose versus high-dose interferon-alfa in chronic myeloid leukemia: prospective collaboration of 3 joint trials by the MRC and HOVON groups

Clinical Trials & Observations
Hanneke C. Kluin-Nelemans, Georgina Buck, Saskia le Cessie, Sue Richards, H. Berna Beverloo, J. H. Frederik Falkenburg, Tim Littlewood, Petra Muus, David Bareford, Hans van der Lelie, Anthony R. Green, Klaas J. Roozendaal, Alison E. Milne, Claire S. Chapman, Patricia Shepherd, for the UK CML Working Group of NCRI and the HOVON trials group
Journal: Blood
Blood (2004) 103 (12): 4408–4415.
https://doi.org/10.1182/blood-2003-10-3605
Published: 2004
Journal Articles

In vitro migratory capacity of CD34 + cells is related to hematopoietic recovery after autologous stem cell transplantation

Carlijn Voermans, Marisha L. K. Kooi, Sjoerd Rodenhuis, Hans van der Lelie, C. Ellen van der Schoot, Winald R. Gerritsen
Journal: Blood
Blood (2001) 97 (3): 799–804.
https://doi.org/10.1182/blood.V97.3.799
Published: 2001